News

Six Central Massachusetts communities earned a total of seven state grants announced late Thursday aimed at improving urban neighborhoods.

UMass Medical School is looking to expand enrollment in a study seeking to find out whether giving blood plasma of recovered COVID-19 patients can prevent others from getting severe cases of the disease.

The pharmaceutical giant Bristol Myers Squibb is expanding its Devens facility by 244,000 square feet, including hundreds of new jobs in areas including cell therapy development and manufacturing.

New business startups thrive in times of stress and change, making this – hopefully, the back end of the coronavirus pandemic – the time the Central Massachusetts business community can bring its resources to bear to support our newest entrepreneurs.

Creating and fostering a strong remote workplace culture helps not only retain existing employees but can attract job seekers as well. A positive company culture – even when work is remote – shines through.

A biotechnology company working on a vaccine to prevent HIV, whose work is licensed by UMass Medical School in Worcester, has won U.S. Food and Drug Administration approval to advance its clinical work.

When will you feel comfortable entering a post-pandemic life? An Instagram conversation makes its way to the airways.

In a year with a lot of bad news, we have some good to share.

New coronavirus cases have nosedived in the past week, offering a promising trend as numbers come down from all-time highs during the pandemic.

With the incoming President Joe Biden Administration, fresh resources will be brought to bear to accelerate testing and tracing programs, as well as new plans for mass inoculations.